Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Other Accumulated Expenses (2024 - 2026)

Core Scientific has reported Other Accumulated Expenses over the past 3 years, most recently at $20.2 million for Q1 2026.

  • Quarterly results put Other Accumulated Expenses at $20.2 million for Q1 2026, changed N/A from a year ago — trailing twelve months through Mar 2026 was $20.2 million (changed N/A YoY), and the annual figure for FY2025 was $15.8 million, down 51.44%.
  • Other Accumulated Expenses reached $20.2 million in Q1 2026 per CORZ's latest filing, up from $15.8 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $32.5 million in Q4 2024 and bottomed at $15.7 million in Q3 2025.
  • Median Other Accumulated Expenses over the past 3 years was $16.9 million (2025), compared with a mean of $20.2 million.
  • Peak annual rise in Other Accumulated Expenses hit 51.44% in 2025, while the deepest fall reached 51.44% in 2025.
  • Over 3 years, Other Accumulated Expenses stood at $32.5 million in 2024, then tumbled by 51.44% to $15.8 million in 2025, then increased by 28.01% to $20.2 million in 2026.
  • Business Quant data shows Other Accumulated Expenses for CORZ at $20.2 million in Q1 2026, $15.8 million in Q4 2025, and $15.7 million in Q3 2025.